A Phase III, Open-Label, Randomized Study of MPDL3280A (Anti−Pd-L1 Antibody) in Combination with Carboplatin+ Paclitaxel with or without Bevacizumab Compared with Carboplatin+Paclitaxel+ Bevacizumab In Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non−Small Cell Lung Cancer

UCI-15-19
NCT02366143
Cancer - Lung
Sai-Hong Ignatius Ou
Open
Treatment
III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.